Specify a stock or a cryptocurrency in the search bar to get a summary
Linical Co Ltd
2183Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan. Address: Shin-Osaka Brick Building, Osaka, Japan, 532-0003
Analytics
WallStreet Target Price
420 443.33 JPYP/E ratio
24.4295Dividend Yield
4.14 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 2183
Dividend Analytics 2183
Dividend growth over 5 years
27 %Continuous growth
1 yearPayout Ratio 5 years average
36 %Dividend History 2183
Stock Valuation 2183
Financials 2183
Results | 2019 | Dynamics |